Please Wait.....
Report
Preclinical CRO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service (Bioanalysis and DMPK studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others), By Model Type (Patient Derived Organoid (PDO) Model, Patient derived xenograft model), By End-Use Industry (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies), By Region and Competition, 2020-2030F
Market Report I 2025-05-16 I 188 Pages I TechSci Research
Market Overview
The Global Preclinical CRO Market was valued at USD 6.24 billion in 2024 and is projected to reach USD 10.15 billion by 2030, growing at a CAGR of 8.45% during the forecast period. This market plays a crucial role in the drug development ecosystem by providing essential services that support pharmaceutical, biotechnology, and medical device companies in their preclinical research activities. Preclinical CROs offer a range of services including bioanalysis, toxicology, safety pharmacology, and compound management, helping clients meet regulatory requirements while improving efficiency and cost-effectiveness. The market is benefiting from the increased outsourcing of early-stage research, as companies seek to streamline operations and focus on core competencies. The rise in drug discovery efforts, technological advancements in research models, and demand for specialized scientific expertise are further driving market growth across regions.
Key Market Drivers
Increasing Outsourcing Trends Drives the Market Growth
A major growth driver for the Global Preclinical CRO Market is the increasing trend of outsourcing among pharmaceutical and biotechnology companies. By outsourcing preclinical R&D activities to specialized CROs, companies are able to significantly reduce costs associated with facility maintenance, personnel, and equipment. CROs offer advanced infrastructure and expert staff, allowing sponsors to accelerate timelines while ensuring regulatory compliance. This model also provides scalability, enabling companies to adapt to changing project demands without major internal investments. Moreover, CROs grant access to cutting-edge technologies and methodologies, helping clients improve research outcomes while focusing internal resources on clinical trials, regulatory strategies, and commercialization. As the demand for efficient and flexible research solutions continues to rise, outsourcing remains a preferred strategy, bolstering the growth of the preclinical CRO sector globally.
Key Market Challenges
Regulatory Compliance and Quality Assurance
The Global Preclinical CRO Market faces considerable challenges due to complex regulatory requirements and the need for strict quality assurance. Regulatory bodies such as the FDA and EMA impose rigorous standards that CROs must meet to ensure that studies are conducted ethically, accurately, and in compliance with international guidelines. Navigating diverse and evolving regulations across multiple geographies adds complexity, particularly for CROs working with global clients. Maintaining compliance requires ongoing investment in specialized personnel, documentation systems, quality audits, and training, which can strain operational resources. Delays or errors in regulatory adherence may lead to costly project setbacks or non-approval of drug candidates in later stages, underscoring the critical need for continuous regulatory vigilance and operational excellence in the CRO landscape.
Key Market Trends
Increase in the Number of Virtual Trials
A significant trend transforming the Global Preclinical CRO Market is the growing adoption of virtual or decentralized clinical trials, which leverage digital tools to collect patient data remotely. Although primarily impacting clinical phases, this trend is influencing preclinical CROs to expand their technological capabilities and align with integrated drug development models. CROs are now incorporating wearable devices, mobile apps, and telehealth platforms to facilitate remote monitoring and data collection, enabling smoother transitions from preclinical to clinical stages. These digital advancements enhance patient recruitment, diversify participation, and improve data accuracy. As a result, CROs are partnering with tech providers and investing in secure data infrastructure to support virtual research models, thereby optimizing trial efficiency and reducing dependency on traditional site-based models.
Key Market Players
- Eurofins Scientific SE
- PRA Health Sciences, Inc.
- Wuxi AppTec
- Medpace, Inc.
- Charles River Laboratories International, Inc.
- PPD, Inc.
- SGA SA
- Intertek Group Plc
- LABCORP Inc.
- Crown Bioscience Inc
Report Scope:
In this report, the Global Preclinical CRO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Preclinical CRO Market, By Service:
o Bioanalysis and DMPK Studies
o Toxicology Testing
o Compound Management
o Chemistry
o Safety Pharmacology
o Others
- Preclinical CRO Market, By Model Type:
o Patient Derived Organoid (PDO) Model
o Patient Derived Xenograft Model
- Preclinical CRO Market, By End User Industry:
o Biopharmaceutical Companies
o Government and Academic Institutes
o Medical Device Companies
- Preclinical CRO Market, By Region:
o North America
United States
Canada
Mexico
o Asia-Pacific
China
India
South Korea
Australia
Japan
o Europe
Germany
France
United Kingdom
Spain
Italy
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Preclinical CRO Market.
Available Customizations:
Global Preclinical CRO Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Preclinical CRO Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service (Bioanalysis and DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others)
5.2.2. By Model Type (Patient Derived Organoid (PDO) Model, Patient derived xenograft model)
5.2.3. By End-Use Industry (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Preclinical CRO Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service
6.2.2. By Model Type
6.2.3. By End-Use Industry
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Preclinical CRO Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Model Type
6.3.1.2.3. By End-Use Industry
6.3.2. Mexico Preclinical CRO Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Model Type
6.3.2.2.3. By End-Use Industry
6.3.3. Canada Preclinical CRO Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Model Type
6.3.3.2.3. By End-Use Industry
7. Europe Preclinical CRO Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Model Type
7.2.3. By End-Use Industry
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Preclinical CRO Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Model Type
7.3.1.2.3. By End-Use Industry
7.3.2. Germany Preclinical CRO Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Model Type
7.3.2.2.3. By End-Use Industry
7.3.3. United Kingdom Preclinical CRO Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Model Type
7.3.3.2.3. By End-Use Industry
7.3.4. Italy Preclinical CRO Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Model Type
7.3.4.2.3. By End-Use Industry
7.3.5. Spain Preclinical CRO Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Model Type
7.3.5.2.3. By End-Use Industry
8. Asia-Pacific Preclinical CRO Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Model Type
8.2.3. By End-Use Industry
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Preclinical CRO Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Model Type
8.3.1.2.3. By End-Use Industry
8.3.2. India Preclinical CRO Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Model Type
8.3.2.2.3. By End-Use Industry
8.3.3. South Korea Preclinical CRO Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Model Type
8.3.3.2.3. By End-Use Industry
8.3.4. Japan Preclinical CRO Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Model Type
8.3.4.2.3. By End-Use Industry
8.3.5. Australia Preclinical CRO Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Model Type
8.3.5.2.3. By End-Use Industry
9. South America Preclinical CRO Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Model Type
9.2.3. By End-Use Industry
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Preclinical CRO Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Model Type
9.3.1.2.3. By End-Use Industry
9.3.2. Argentina Preclinical CRO Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Model Type
9.3.2.2.3. By End-Use Industry
9.3.3. Colombia Preclinical CRO Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Model Type
9.3.3.2.3. By End-Use Industry
10. Middle East and Africa Preclinical CRO Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service
10.2.2. By Model Type
10.2.3. By End-Use Industry
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Preclinical CRO Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Model Type
10.3.1.2.3. By End-Use Industry
10.3.2. Saudi Arabia Preclinical CRO Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Model Type
10.3.2.2.3. By End-Use Industry
10.3.3. UAE Preclinical CRO Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.3.2.2. By Model Type
10.3.3.2.3. By End-Use Industry
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. Competitive Landscape
15.1. Eurofins Scientific SE
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. PRA Health Sciences, Inc.
15.3. Wuxi AppTec
15.4. Medpace, Inc.
15.5. Charles River Laboratories International, Inc.
15.6. PPD, Inc.
15.7. SGA SA
15.8. Intertek Group Plc
15.9. LABCORP, Inc.
15.10. Crown Bioscience Inc
16. Strategic Recommendations
17. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security